Search Results - "Loretz, B."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Nanoparticles made from novel starch derivatives for transdermal drug delivery by Santander-Ortega, M.J., Stauner, T., Loretz, B., Ortega-Vinuesa, J.L., Bastos-González, D., Wenz, G., Schaefer, U.F., Lehr, C.M.

    Published in Journal of controlled release (04-01-2010)
    “…The goal of this paper was aimed to the formulation of nanoparticles by using two different propyl-starch derivatives – referred to as PS-1 and PS-1.45 – with…”
    Get full text
    Journal Article
  2. 2

    Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin by Nafee, N., Hirosue, M., Loretz, B., Wenz, G., Lehr, C.-M.

    Published in Colloids and surfaces, B, Biointerfaces (01-05-2015)
    “…•Cyclodextrin-based star polymers containing MMA and tBA as hydrophobic arms.•Star polymers were used to prepare idarubicin-loaded nanoparticles.•Nanoparticles…”
    Get full text
    Journal Article
  3. 3

    Telomerase as an emerging target to fight cancer — Opportunities and challenges for nanomedicine by Philippi, C., Loretz, B., Schaefer, U.F., Lehr, C.M.

    Published in Journal of controlled release (01-09-2010)
    “…Telomerase as an enzyme is responsible for the renewal of the chromosomal ends, the so-called telomeres. By preventing them from shortening with each cell…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Correlation of in vitro and in vivo models for the oral absorption of peptide drugs by Föger, F, Kopf, A, Loretz, B, Albrecht, K, Bernkop-Schnürch, A

    Published in Amino acids (01-06-2008)
    “…The aim of this study was to evaluate two in vitro models, Caco-2 monolayer and rat intestinal mucosa, regarding their linear correlation with in vivo…”
    Get full text
    Journal Article
  5. 5

    Pulmonary delivery and tissue distribution of aerosolized antisense 2′-O-Methyl RNA containing nanoplexes in the isolated perfused and ventilated rat lung by Dong, M., Mürdter, T.E., Philippi, C., Loretz, B., Schaefer, U.F., Lehr, C.-M., Schwab, M., Ammon-Treiber, S.

    “…Lung physiology and tissue distribution of 2′-O-Methyl RNA after administration of aerosolized nanoplexes in the isolated perfused and ventilated rat lung…”
    Get full text
    Journal Article
  6. 6

    Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles by Föger, Florian, Noonpakdee, Wilai, Loretz, Brigitta, Joojuntr, Songwut, Salvenmoser, Willi, Thaler, Marlene, Bernkop-Schnürch, Andreas

    Published in International journal of pharmaceutics (17-08-2006)
    “…New effective antimalarial agents are urgently needed due to increasing drug resistance of Plasmodium falciparum. Phosphorothioate antisense…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Biodynamer Nano-Complexes and -Emulsions for Peptide and Protein Drug Delivery by Liu, Yun, Hamm, Timo, Eichinger, Thomas Ralf, Kamm, Walter, Wieland, Heike Andrea, Loretz, Brigitta, Hirsch, Anna K H, Lee, Sangeun, Lehr, Claus-Michael

    Published in International journal of nanomedicine (01-01-2024)
    “…Therapeutic proteins and peptides offer great advantages compared to traditional synthetic molecular drugs. However, stable protein loading and precise control…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion by Loretz, Brigitta, Föger, Florian, Werle, Martin, Bernkop-schnürch, Andreas

    Published in Journal of drug targeting (01-01-2006)
    “…Purpose: Gastrointestinal (GI) nucleases are responsible for a rapid presystemic degradation of orally administered transgenes. Within the current study, the…”
    Get full text
    Journal Article
  15. 15

    Design and evaluation of a chitosan-aprotinin conjugate for the peroral delivery of therapeutic peptides and proteins susceptible to enzymatic degradation by Werle, Martin, Loretz, Brigitta, Entstrasser, Daniel, Föger, Florian

    Published in Journal of drug targeting (01-01-2007)
    “…One main barrier for the peroral administration of therapeutic peptides and proteins is the enzymatic barrier, that is mediated by luminally secreted and…”
    Get full text
    Journal Article
  16. 16

    Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan by Föger, Florian, Kafedjiiski, Krum, Hoyer, Herbert, Loretz, Brigitta, Bernkop-Schnürch, Andreas

    Published in Journal of drug targeting (01-01-2007)
    “…It was the aim of this study to investigate the effect of chitosan-4-thiobutylamidine (Ch-TBA) and reduced glutathione (GSH) on the absorption of…”
    Get full text
    Journal Article
  17. 17